21Aug 2023
Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas

Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas

A study found that p‐Akt, a protein associated with PTEN deficiency and melanoma tumorigenesis, is expressed in 32.1% of acral, 68.4% of Low-CSD, and 55.6% of High-CSD melanomas. NUAK2, another protein, is expressed in 46.4%, 76.3%, and 50.0% of these melanomas, respectively. Both p‐Akt and NUAK2 expression were linked to worse relapse-free survival (RFS) in primary melanoma patients and acral melanoma patients. Importantly, p‐Akt significantly impacted RFS (Hazard ratio = 4.454; p < .0001), especially in acral melanoma patients (Hazard ratio = 4.036; p = .0005). This suggests that p‐Akt expression can predict relapse in patients with primary melanomas, particularly those with acral melanomas.

  • #dermatology

Like

Save

Share